References
- Palucka K, Banchereau J. Dendritic-cell-based therapeutic cancer vaccines. Immun. 2013; 39(1):38-48; PMID:23890062; http://dx.doi.org/10.1016/j.immuni.2013.07.004
- Steinman RM. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol. 2012; 30:1-22; PMID:22136168; http://dx.doi.org/10.1146/annurev-immunol-100311-102839
- Hawiger D, Inaba K, Dorsett Y, Guo M, Mahnke K, Rivera M, Ravetch JV, Steinman RM, Nussenzweig MC. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J Exp Med. 2001; 194(6):769-79; PMID:11560993; http://dx.doi.org/10.1084/jem.194.6.769
- Tsuji T, Matsuzaki J, Kelly MP, Ramakrishna V, Vitale L, He LZ, Keler T, Odunsi K, Old LJ, Ritter G, et al. Antibody-targeted NY-ESO-1 to mannose receptor or DEC-205 in vitro elicits dual human CD8+ and CD4+ T cell responses with broad antigen specificity. J Immunol. 2011; 186(2):1218-27; PMID:21149605; http://dx.doi.org/10.4049/jimmunol.1000808
- Cheong C, Choi JH, Vitale L, He LZ, Trumpfheller C, Bozzacco L, Do Y, Nchinda G, Park SH, Dandamudi DB, et al. Improved cellular and humoral immune responses in vivo following targeting of HIV Gag to dendritic cells within human anti-human DEC205 monoclonal antibody. Blood. 2010; 116(19):3828-38; PMID:20668230; http://dx.doi.org/10.1182/blood-2010-06-288068
- Dhodapkar MV, Sznol M, Zhao B, Wang D, Carvajal RD, Keohan ML, Chuang E, Sanborn RE, Lutzky J, Powderly J, et al. Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205. Sci Transl Med. 2014; 6(232):232ra51; PMID:24739759; http://dx.doi.org/10.1126/scitranslmed.3008068
- Dhodapkar KM, Gettinger SN, Das R, Zebroski H, Dhodapkar MV. SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer. Oncoimmunology. 2013; 2(7):e25205; PMID:24073380; http://dx.doi.org/10.4161/onci.25205
- Paulis LE, Mandal S, Kreutz M, Figdor CG. Dendritic cell-based nanovaccines for cancer immunotherapy. Curr Opin Immunol. 2013; 25(3):389-95; PMID:23571027; http://dx.doi.org/10.1016/j.coi.2013.03.001
- Sehgal K, Ragheb RTF, Dhodapkar M, Dhodapkar K. Nanoparticle-mediated combinatorial targeting of multiple human dendritic cell (DC) subsets leads to enhanced T cell activation via IL15-dependent DC cross-talk. J Immunol. 2014; in press; PMID:25080481
- Pulendran B, Tang H, Denning TL. Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr Opin Immunol. 2008; 20(1):61-7; PMID:18082389; http://dx.doi.org/10.1016/j.coi.2007.10.009